the company has stated [colaris] is its fastest growing product
MYGN was also talking about a $360M market size. Perhaps they need marketing effort to address men as well. The melanoma risk test is a small indication but I though the 5-FU test could be nearly as big as colaris.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.